MDLinx and MMIT connect to aid HCPs
By Mia Burns (email@example.com)
MDLinx and MMIT are combining their strengths to deliver high quality information directly to hundreds of thousands of physicians via MDLinx’s No. 1 ranked specialty website. MDLinx is part of M3 Group and executives say that the company educates and updates nearly half a million U.S. healthcare professionals with trusted clinical and medical information. MMIT provides trusted formulary data and software solutions to payers, pharmaceutical manufacturers, and physicians to help them make informed managed care decisions.
“MMIT works directly with their clients on new and innovative ways to educate healthcare professionals and promote today’s top pharma brands in an accurate and highly credible way,” says Jack Bilson III, VP, product innovation, M3 Group. “As part of our new partnership together, MMIT’s team of pharmacy professionals has been trained and educated on the extensive reach and breakdown that MDLinx has among healthcare providers in the United States. This allows the MMIT team to support pharma stakeholders, frame highly effective web based alerts, and email notifications. These communication streams leverage MMIT data rapidly and consistently, updating specific formulary changes in a particular state or region that impacts a client’s particular products status. The key is that this communication can be customized for a variety of targeted campaigns and timed to coincide with key events such as the coverage of new drugs. In turn, this information is what the healthcare professionals need in order to help them make more informed prescribing decisions based on market changes.”
The need for timely targeted access to formulary information continues to grow in importance for physicians, helping them make more informed pharmaceutical product choices for their patients, the companies claim. This new promotional partnership will give more pharma brands the opportunity to run targeted campaigns that use MMIT’s data with the extensive healthcare professionals’ coverage of MDLinx.
Bilson also told Med Ad News Daily, “The timeliness and complexities of pharma market access data, for example, from the proliferation of specialty drugs or the addition of formularies for health exchanges, has been getting more sophisticated and more vital very year. The high quality of MMIT data and the collaborative work approach between MMIT and their clients made them a great partner candidate for M3 Group, the parent company of MDLinx. M3 Group is always searching for innovative ways to better serve our healthcare professionals members as well as the pharma and life science industries; working with MMIT we were able to achieve both with a single partner.”
Healthcare professionals are frequently challenged in obtaining the most current formulary status of pharma products specific to their region, according to Bilson. “From the healthcare professional point of view, these new formulary changes are often not updated or communicated to them in a timely fashion, or even at all,” he told Med Ad News Daily. “To insure that busy healthcare professionals stay current, this critical information often requires multiple channels of communication to reach them. This partnership lets us make sure the healthcare professionals see the same information in their office, too. Surveys done with MDLinx members have shown a growing interest by healthcare professionals in receiving this type of information. MDLinx continues to be the leading provider and aggregator of impactful practical medical information helping to keep busy healthcare professionals current in the field of medicine. This new offering just continues our mission.”
Posted: September 2013